Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2007 Mar;11(3):338-44.
doi: 10.1007/s11605-006-0069-8.

Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas

Affiliations

Predictive factors of malignant or invasive intraductal papillary-mucinous neoplasms of the pancreas

Yoshiaki Murakami et al. J Gastrointest Surg. 2007 Mar.

Abstract

The aim of this study was to identify useful preoperative diagnostic findings indicative of malignant or invasive intraductal papillary-mucinous neoplasms (IPMN) of the pancreas to determine an optimal operative procedure for IPMN. Sixty-two IPMNs, which consisted of 29 adenomas, 10 borderline tumors, 11 adenocarcinomas in situ, and invasive adenocarcinomas were reviewed from 1990 to 2003. Preoperative predictive factors of malignant or invasive IPMN were analyzed among 10 factors by univariate and multivariate analysis. Diameter of the main pancreatic duct (> or =6 mm) and cytological examination of the pancreatic juice (the presence of malignant cells) were identified as independent predictive factors of malignant IPMN, and only cytological examination of the pancreatic juice (the presence of malignant cells) was identified as an independent predictor of invasive IPMN by multivariate analysis (P < 0.05). There was no recurrent disease in patients with adenoma and adenocarcinoma in situ, whereas recurrences occurred in 6 of 12 patients with invasive IPMN. Patient survival in noninvasive IPMN was significantly (P = 0.018) better than that in invasive IPMN (The overall 5-year survival rates were 87.2% and 49.2%, respectively). These results might be useful for selecting an optimal surgical procedure for IPMN.

PubMed Disclaimer

References

    1. Am J Gastroenterol. 2000 Feb;95(2):441-5 - PubMed
    1. Gastroenterology. 2002 Nov;123(5):1500-7 - PubMed
    1. Cancer. 1997 Jun 25;81(3):163-71 - PubMed
    1. Gut. 2002 Nov;51(5):717-22 - PubMed
    1. Surgery. 1997 Sep;122(3):617-25 - PubMed

MeSH terms

LinkOut - more resources